December 1, 2023
CRLB-GMEL hosts the Second Annual Multiomics Day
The Clinical Research Laboratory and Biobank- Genetic and Molecular Epidemiology Laboratory (CRLB-GMEL) recently hosted the Second Annual Multiomics Day at...
Read MoreDecember 1, 2023
The Clinical Research Laboratory and Biobank- Genetic and Molecular Epidemiology Laboratory (CRLB-GMEL) recently hosted the Second Annual Multiomics Day at...
Read MoreDecember 1, 2023
PHRI’s Executive Director and Senior Scientist Salim Yusuf, Senior Scientist John Eikelboom, Senior Scientist Stuart Connolly, and Associate Senior Scientist Paul...
Read MoreNovember 13, 2023
The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable...
Read MoreNovember 6, 2023
On November 1st the PHRI research community gathered for the Perioperative Care Lectureship Event, featuring the esteemed Dr. Christian Mueller,...
Read MoreOctober 30, 2023
PHRI Investigator, William McIntyre received the 2023 Canadian Cardiovascular Society (CCS) Young Investigator Award at the annual Canadian Cardiovascular Congress...
Read MoreOctober 24, 2023
In honor of Janice Pogue, the visionary founder of PHRI’s statistical group, PHRI researchers convened for the 6th Annual Janice...
Read MoreOctober 20, 2023
PHRI Scientist Marie Pigeyre received the 2023 Cardiometabolic Research Award. This esteemed recognition was presented by the Canadian Cardiovascular Society...
Read MoreOctober 20, 2023
PHRI Scientist Ashkan Shoamanesh wants physicians treating intracranial hemorrhage (ICrH) survivors with atrial fibrillation (Afib) to proceed with caution when...
Read MoreOctober 12, 2023
Seven of PHRI distinguished Principal Investigators (PIs) have come together with over 3600 fellow stroke experts worldwide for the 15th...
Read MoreAugust 29, 2023
PHRI Senior Scientist and Deputy Director, Hertzel Gerstein, has been elected as a Fellow in the Royal Society of Canada...
Read MoreAugust 28, 2023
Physical frailty is a characteristic that should be evaluated to assess the risk of poor outcomes in patients with heart...
Read MoreAugust 26, 2023
More than half of all heart attacks and strokes are avoidable by checking and treating the five most common cardiovascular...
Read MoreAugust 25, 2023
A large, international study in patients undergoing non-cardiac thoracic surgery found that the anti-inflammatory drug, colchicine, did not significantly reduce...
Read MoreAugust 18, 2023
More than $6.1 million has been awarded in total to PHRI studies in the Spring 2023 project grant competition of...
Read MoreAugust 14, 2023
In an interview during the European Stroke Organisation Conference (ESOC 2023) in Munich, Germany, PHRI Scientist Ashkan Shoamanesh, in a video...
Read MoreBack To Top